Page last updated: 2024-10-26

dimaprit and Breast Cancer

dimaprit has been researched along with Breast Cancer in 1 studies

Dimaprit: A histamine H2 receptor agonist that is often used to study the activity of histamine and its receptors.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Goel, AK1
Zamre, V1
Chaudhary, P1
Sharma, G1
Singh, D1

Other Studies

1 other study available for dimaprit and Breast Cancer

ArticleYear
APT Trial: Would It Really Help in De-Escalation of Therapy?
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2019, 11-01, Volume: 37, Issue:31

    Topics: Breast Neoplasms; Dimaprit; Follow-Up Studies; Humans; Paclitaxel; Receptor, ErbB-2; Trastuzumab

2019